🇺🇸 Triptorelin acetate （3.75mg） in United States

Triptorelin acetate （3.75mg） (Triptorelin acetate （3.75mg）) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Triptorelin acetate （3.75mg） in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Triptorelin acetate （3.75mg） approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Triptorelin acetate （3.75mg） in United States?

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.